Market Overview

Benzinga's Top Pre-Market Losers

Related DSW
Credit Suisse Lowers DSW's Price Target
Earnings Scheduled For November 24, 2015
DSW (Investor's Business Daily)
Related INFI
Infinity Announces Enrollment Of 120th Patient In Phase 2 DYNAMO™ Study Evaluating Duvelisib In Indolent Non-Hodgkin Lymphoma
New Biotech Pair Trade: Infinity Pharma Over ImmunoGen

Body Central (NASDAQ: BODY) shares fell 25.33% to $11.94 in the pre-market trading. Body Central issued downbeat Q2 earnings forecast.

Infinity Pharmaceuticals (NASDAQ: INFI) dipped 22.55% to $10.75 in the pre-market session. Infinity Pharmaceuticals stopped mid-stage trials of saridegib in chondrosarcoma and myelofibrosis

DSW (NYSE: DSW) shares dropped 8.59% to $53.75 in pre-market trading. DSW reiterated its 2012 forecast. The company's board also authorized a new $100 million stock buyback program.

Steel Dynamics (NASDAQ: STLD) dipped 4.90% to $10.48 in the pre-market session. Steel Dynamics issued downbeat Q2 earnings forecast.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (DSW + BODY)

Get Benzinga's Newsletters